Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastrointestinal Stromal Tumors × ponatinib × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Blast Crisis 5 Leukemia, Myeloid, Accelerated Phase 4 Leukemia 4 Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Acute 2 Piebaldism 1 Neoplasms by Histologic Type 1 Myeloproliferative Disorders 1 Lymphoma 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Bone Marrow Diseases 1

Interventions

Imatinib Mesylate 10 Sunitinib 7 ripretinib 4 Blood Specimen Collection 3 regorafenib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 IDRX-42 2 Biopsy 2 trastuzumab deruxtecan 1 spartalizumab 1 ribociclib 1 pemigatinib 1 palbociclib 1 guadecitabine 1 envafolimab 1 binimetinib 1 avelumab 1 avapritinib 1 atezolizumab 1 Sorafenib 1 Rogaratinib 1 Quality Assurance, Health Care 1 Observation 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Cyclophosphamide 1 Control Groups 1 Clobetasol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡